|
Aurobindo Pharma Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
91749.23 Cr.
|
P/BV
|
2.42
|
Book Value (Rs.)
|
652.39
|
|
52 Week High/Low (Rs.)
|
1637/1016
|
FV/ML
|
1/1
|
P/E(X)
|
26.18
|
|
Bookclosure
|
17/04/2026
|
EPS (Rs.)
|
60.34
|
Div Yield (%)
|
0.25
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 5110.33 | 5066.29 | 4379.99 | 2612.50 | 3372.74 |
| | | | | | |
| Net CashFlow From Operating Activities | 5526.37 | 3924.62 | 2434.52 | 2386.75 | 5016.48 |
| Net Cash Used In Investing Activities | -3458.43 | -1875.80 | -4255.95 | -3977.75 | -3211.56 |
| Net Cash Used From Financing Activities | -1269.15 | 119.78 | 800.42 | 1814.41 | -2969.27 |
| Foreign Exchange Gains / Losses | 828.82 | 9.10 | 14.17 | -0.06 | 0.20 |
| Adjustments On Amalgamation / Merger / Demerger And Others | 0.00 | 0.66 | 0.00 | 6.41 | -3.25 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 1627.61 | 2178.36 | -1006.84 | 229.76 | -1167.40 |
| Cash And Cash Equivalents Begin of Year | 5563.79 | 3385.43 | 4392.27 | 4162.51 | 5329.91 |
| Cash And Cash Equivalents End Of Year | 7191.40 | 5563.79 | 3385.43 | 4392.27 | 4162.51 |
